Qurient Co., Ltd. — Investor Relations & Filings
Filings indexed
437
across all filing types
Latest filing
2024-01-05
Director's Dealing
Country
KR
South Korea
Listing
KO
115180
Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
10 filings
| |||||
| 8056191 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056189 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056188 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056185 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056180 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056178 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056176 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056172 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056168 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
| 8056164 | [기재정정]임원ㆍ주요주주특정증권등소유상황보고서 | 2024-01-05 | Korean | ||
|
2023
5 filings
| |||||
| 8056208 | 증권발행결과(자율공시)(제1회차 CB) | 2023-12-27 | Korean | ||
| 8056207 | 증권발행결과(자율공시)(제3자배정 유상증자-전환우선주) | 2023-12-27 | Korean | ||
| 8056206 | [기재정정]주요사항보고서(유상증자결정) | 2023-12-27 | Korean | ||
| 8056202 | [기재정정]증권발행결과(자율공시)(제3자배정 유상증자 전환우선주) | 2023-12-27 | Korean | ||
| 8056209 | [기재정정]주요사항보고서(유상증자결정) | 2023-12-26 | Korean | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Qurient Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15457/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15457 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15457 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15457 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15457}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Qurient Co., Ltd. (id: 15457)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.